18 November marked the end of the 11th Ebola outbreak in the Democratic Republic of the Congo (DRC), nearly six months after the first cases were reported in Equateur Province
WHO’s Director-General Tedros Ghebreyesus said the Executive Group of the Solidarity Trial had last week decided to implement a temporary pause of the hydroxychloroquine arm of the trial, “because of concerns raised about the safety of the drug.”
The WHO confirmed 20 new cases of Ebola in the Democratic Republic of Congo this week, along with an additional 12 deaths. However, health officials fear more cases are hidden because warring factions are preventing help to get to those in need. Top U.S. health officials traveled to the epicenter of the outbreak in mid-September, delivering hope and much-needed medicine
As more than 10,000 people have been immunized against the Ebola virus, Gressly said, “vaccination by itself is probably not sufficient to end the epidemic. It can put a break on the spread, slow it down, but, in itself is probably not going to stop the epidemic.”
The UN chief travelled to Mangina, a rural commune in Beni territory where the first case of Ebola was detected one year ago. He met with staff working at the centre for the treatment of the Ebola virus disease
The mortality rate for REGN-EB3 and mAb114 was 29 per cent and 34 per cent respectively, and the drugs worked even better for patients who were treated early -within three days of infection
Witnesses say fears of the Ebola virus have brought border traffic between Rwanda and the Democratic Republic of Congo to a virtual standstill. Long lines and lengthy delays at the border crossings have left many traders frustrated
As of 20 January, 422 people have died in this outbreak, while 245 have survived. Two hundred and seventeen of these survivors are participating in the programme.